Subjective effects of prisoners using buprenorphine for detoxification

Alexander Johnstone, Tim Duffy, Colin Martin

Research output: Contribution to journalArticle

Abstract

Purpose
– Buprenorphine (Subutex) was piloted in two Scottish prisons between 2004 and 2006 and consequently used within other penal establishments in Scotland. This 2007 qualitative study aimed to explore the use of Subutex and its associated effects on 14 participants on detoxification programmes.

Design/methodology/approach
– All participants were male, aged from 21 to 44 years with prison sentences ranging from a few months to life imprisonment. Buprenorphine was unavailable to female prisoners at the time of this study. Participants were recruited from seven Scottish prisons. All 14 participants were on detoxification programmes, each was prescribed Subutex, and each was selected from a larger investigation that included both those undergoing detoxification and maintenance (n=21). All participants had previously also used methadone on previous detoxification programmes.

Findings
– It can be concluded that the majority of detoxification participants within this study indicated that Subutex was a more effective treatment than methadone as it helped reduce craving, eased the process of withdrawal and improved sleeping patterns. In addition, the majority of participants noted higher levels of motivation and the ability to set goals towards obtaining an improved quality of life.

Originality/value
- This study provides an alternative perspective to the use of Subutex within prison settings, when compared with results from previous quantitative studies reported. The study also highlights inconsistencies drawn from studies in this area, which may be an artefact of study design. It is recommended that further qualitative studies be conducted to explore further this alternative perspective. Finally, the issue of methodological approach taken should be addressed within the context of a related, but independent, research forum.
Original languageEnglish
Pages (from-to)52-65
Number of pages14
JournalInternational Journal of Prisoner Health
Volume7
Issue number4
DOIs
Publication statusPublished - 2011

Fingerprint

Buprenorphine
Prisoners
Prisons
Methadone
Aptitude
Time and Motion Studies
Scotland
Artifacts
Motivation
Maintenance
Quality of Life
Research

Keywords

  • Buprenorphine
  • Craving
  • Detoxification
  • Drug addiction
  • Penal
  • Prisoners
  • Qualitative
  • Rehabilitation
  • Scotland
  • Sleep
  • Subutex;
  • Withdrawal

Cite this

@article{34672d83dfeb48299bf7825467815b81,
title = "Subjective effects of prisoners using buprenorphine for detoxification",
abstract = "Purpose– Buprenorphine (Subutex) was piloted in two Scottish prisons between 2004 and 2006 and consequently used within other penal establishments in Scotland. This 2007 qualitative study aimed to explore the use of Subutex and its associated effects on 14 participants on detoxification programmes.Design/methodology/approach– All participants were male, aged from 21 to 44 years with prison sentences ranging from a few months to life imprisonment. Buprenorphine was unavailable to female prisoners at the time of this study. Participants were recruited from seven Scottish prisons. All 14 participants were on detoxification programmes, each was prescribed Subutex, and each was selected from a larger investigation that included both those undergoing detoxification and maintenance (n=21). All participants had previously also used methadone on previous detoxification programmes.Findings– It can be concluded that the majority of detoxification participants within this study indicated that Subutex was a more effective treatment than methadone as it helped reduce craving, eased the process of withdrawal and improved sleeping patterns. In addition, the majority of participants noted higher levels of motivation and the ability to set goals towards obtaining an improved quality of life.Originality/value- This study provides an alternative perspective to the use of Subutex within prison settings, when compared with results from previous quantitative studies reported. The study also highlights inconsistencies drawn from studies in this area, which may be an artefact of study design. It is recommended that further qualitative studies be conducted to explore further this alternative perspective. Finally, the issue of methodological approach taken should be addressed within the context of a related, but independent, research forum.",
keywords = "Buprenorphine, Craving, Detoxification, Drug addiction, Penal, Prisoners, Qualitative, Rehabilitation, Scotland, Sleep, Subutex;, Withdrawal",
author = "Alexander Johnstone and Tim Duffy and Colin Martin",
year = "2011",
doi = "10.1108/17449201111256907",
language = "English",
volume = "7",
pages = "52--65",
journal = "International Journal of Prisoner Health",
issn = "1744-9219",
publisher = "Emerald Publishing Limited",
number = "4",

}

Subjective effects of prisoners using buprenorphine for detoxification. / Johnstone, Alexander ; Duffy, Tim; Martin, Colin.

In: International Journal of Prisoner Health, Vol. 7, No. 4, 2011, p. 52-65.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Subjective effects of prisoners using buprenorphine for detoxification

AU - Johnstone, Alexander

AU - Duffy, Tim

AU - Martin, Colin

PY - 2011

Y1 - 2011

N2 - Purpose– Buprenorphine (Subutex) was piloted in two Scottish prisons between 2004 and 2006 and consequently used within other penal establishments in Scotland. This 2007 qualitative study aimed to explore the use of Subutex and its associated effects on 14 participants on detoxification programmes.Design/methodology/approach– All participants were male, aged from 21 to 44 years with prison sentences ranging from a few months to life imprisonment. Buprenorphine was unavailable to female prisoners at the time of this study. Participants were recruited from seven Scottish prisons. All 14 participants were on detoxification programmes, each was prescribed Subutex, and each was selected from a larger investigation that included both those undergoing detoxification and maintenance (n=21). All participants had previously also used methadone on previous detoxification programmes.Findings– It can be concluded that the majority of detoxification participants within this study indicated that Subutex was a more effective treatment than methadone as it helped reduce craving, eased the process of withdrawal and improved sleeping patterns. In addition, the majority of participants noted higher levels of motivation and the ability to set goals towards obtaining an improved quality of life.Originality/value- This study provides an alternative perspective to the use of Subutex within prison settings, when compared with results from previous quantitative studies reported. The study also highlights inconsistencies drawn from studies in this area, which may be an artefact of study design. It is recommended that further qualitative studies be conducted to explore further this alternative perspective. Finally, the issue of methodological approach taken should be addressed within the context of a related, but independent, research forum.

AB - Purpose– Buprenorphine (Subutex) was piloted in two Scottish prisons between 2004 and 2006 and consequently used within other penal establishments in Scotland. This 2007 qualitative study aimed to explore the use of Subutex and its associated effects on 14 participants on detoxification programmes.Design/methodology/approach– All participants were male, aged from 21 to 44 years with prison sentences ranging from a few months to life imprisonment. Buprenorphine was unavailable to female prisoners at the time of this study. Participants were recruited from seven Scottish prisons. All 14 participants were on detoxification programmes, each was prescribed Subutex, and each was selected from a larger investigation that included both those undergoing detoxification and maintenance (n=21). All participants had previously also used methadone on previous detoxification programmes.Findings– It can be concluded that the majority of detoxification participants within this study indicated that Subutex was a more effective treatment than methadone as it helped reduce craving, eased the process of withdrawal and improved sleeping patterns. In addition, the majority of participants noted higher levels of motivation and the ability to set goals towards obtaining an improved quality of life.Originality/value- This study provides an alternative perspective to the use of Subutex within prison settings, when compared with results from previous quantitative studies reported. The study also highlights inconsistencies drawn from studies in this area, which may be an artefact of study design. It is recommended that further qualitative studies be conducted to explore further this alternative perspective. Finally, the issue of methodological approach taken should be addressed within the context of a related, but independent, research forum.

KW - Buprenorphine

KW - Craving

KW - Detoxification

KW - Drug addiction

KW - Penal

KW - Prisoners

KW - Qualitative

KW - Rehabilitation

KW - Scotland

KW - Sleep

KW - Subutex;

KW - Withdrawal

U2 - 10.1108/17449201111256907

DO - 10.1108/17449201111256907

M3 - Article

VL - 7

SP - 52

EP - 65

JO - International Journal of Prisoner Health

JF - International Journal of Prisoner Health

SN - 1744-9219

IS - 4

ER -